🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 60% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
30 Servings
Botanical with Nutrients Product Type
60% Evidence Coverage

Supplement Facts — Evidence Check

100 mg
📊 833.3× RDA — above typical dose 📚 273 studies (Tier A: 9, B: 175)
RDA 0.12mg This product: 100mg
50 mcg (250% DV)
📊 3.3× RDA — above typical dose (UL: 0.1 mg) 📚 604 studies (Tier A: 16, B: 251)
RDA 0.015mg This product: 0.05mg UL 0.1mg
Cissus quadrangularis extract
350 mg
Cissus quadrangularis, Powder
350 mg
1400 mg (23.53% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 1400mg

Other Ingredients

Cellulose Rice Flour Vegetable Oil, Powder Silica Maltodextrin

Label Claims — Verification

All Other
Structure/Function
All Other (100% of products) Structure/Function (84% of products) Nutrient (73% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating) Gluten Free Dairy Free Sugar Free

Product Information

📋 Directions for Use

Suggested Use: As a dietary supplement, adults take one (1) capsule three times (3x) daily, with food, or as recommended by a healthcare professional.

⚠️ Warnings & Precautions

Warning: Do not use if you are pregnant, attempting to become pregnant, or nursing. Consult a healthcare professional before using this or any other dietary supplement, especially if you have or suspect you may have any medical condition, or if you are taking anticoagulants, any other dietary supplement, prescription, or over-the-counter medications, as combining these products may cause side effects.

Discontinue use and immediately call a healthcare professional if you experience any adverse reactions. Do not exceed recommended serving. Read entire label prior to use.

Keep out of reach of individuals under the age of 18.

Do not use if safety seal is damaged or missing.

🧪 Formulation Notes

Bone health supplement

Gluten-free Soy-free Non-GMO Dairy-free Sugar-free Shellfish-free

2100 mg With Vitamins K2 & D3

Bone health & density support Encourages healthy bone formation Improves calcium absorption Helps strengthen bones

Preservative free

Additional Information

New

Store in a cool, dry place.

GMP Practice Good Manufacturing Made in the Unites States

Follow us: @EssentialElementsNutrition

Product Details

UPC / SKU X002D1LXYH
DSLD Entry Date 2022-11-22
Product Type Botanical with Nutrients
Form Capsule
DSLD ID 275154
Data Updated 2026-04-11

Research Evidence

332 Research Sources
59 Avg Quality Score
220 Meta Analysis
56 Systematic Review
30 Rct
16 Clinical Trial
3 Guideline
3 Regulatory Source
1 Narrative Review
1 Other
1 Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014
View all evidence for Vitamin K →

Compare Similar Products

View all Vitamin K products →